1 terminated, 1 withdrawn. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow alpha-Thalassemia: new trials by email Literature Review of alpha-Thalassemia trials Research Report on alpha-Thalassemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM) in utero hematopoietic stem cell transplantation - Alpha Thalassemia Major, Hemoglobinopathy; With Thalassemia | Phase 1 | Terminated | University of California, San Francisco | 6 | 2017-10-05 | 2025-01-27 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies Enriched Hematopoetic Stem Cell Infusion - Anemia, Sickle Cell, Complex and Transfusion-dependent Hemoglobinopathies | Phase 1 / Phase 2 | Withdrawn | Talaris Therapeutics Inc. | 2011-05-01 | 2023-03-03 |
Thalassemia (2) · beta-Thalassemia (2) · Anemia, Diamond-Blackfan (1) · Anemia, Sickle Cell (1) · Bone Marrow Failure Disorders (1) · Hemoglobinopathies (1) · Hydrops Fetalis (1)
Anemia (2) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Anemia, Aplastic (1) · Anemia, Hypoplastic, Congenital (1) · Bone Marrow Diseases (1) · Congenital Bone Marrow Failure Syndromes (1) · Edema (1) · Erythroblastosis, Fetal (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Fetal Diseases (1)
Talaris Therapeutics Inc. (1) · University of California, San Francisco (1)
United States (2)
Suzanne T Ildstad, MD (1) · Tippi Mackenzie, MD (1)